- Home
- DYN vs INDB Comparison
DYN vs INDB Comparison
Compare DYN & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYN | INDB |
|---|---|---|
| Founded | 1984 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.0B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DYN | INDB |
|---|---|---|
| Price | $17.14 | $80.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | $37.00 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 3.0M | 254.9K |
| Earning Date | 05-04-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.33 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $33.83 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $24.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.92 | $63.33 |
| 52 Week High | $27.31 | $87.50 |
Technical Indicators
Market Signals| Indicator | DYN | INDB |
|---|---|---|
| Relative Strength Index (RSI) | 24.40 | 41.88 |
| Support Level | $16.55 | $79.61 |
| Resistance Level | $19.54 | $81.80 |
| Average True Range (ATR) | 1.10 | 1.46 |
| MACD | -0.43 | -0.06 |
| Stochastic Oscillator | 5.73 | 36.24 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.